Preparing your space
Preparing your space
Conditions & Recovery · ASCO Daily News · May 31, 2026
Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma. LINK TO FULL TRANSCRIPT
Originally published by ASCO Daily News. We curate and add context; they did the reporting.
Read the full story at ASCO Daily News ↗